Clinical Handbook of Psychotropic Drugs

Quick and comprehensive information on psychotropic drugs for adults.

Accurate and up-to-date
Comparison charts help decision-making
Icons and full color
Available both in print and online
Downloadable patient information sheets

More about this book
The ###ITALIC#TEXT[Clinical Handbook of Psychotropic Drugs]### has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

Independent, unbiased, up-to-date
Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
Potential interactions and side effects summarized in comparison charts
With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek

This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.
Clearly written patient information sheets can be downloaded as printable PDF files from the Hogrefe website after registration
New in this edition

Antidepressants chapter revised extensively and includes new sections on the selective serotonin-1A agonist gepirone and difficult-to-treat depression
Antipsychotics chapter includes a new section on the muscarinic agonist/antagonist combination (Xanomeline/trospium chloride), a novel treatment that does not block D2 dopamine receptors. Major revisions to TGA Dosing and Pharmacokinetics
Drugs for ADHD comparison table expanded
Drugs of Abuse chapter has been revised extensively and includes a new section on Psychedelics and Dissociative Drugs
New formulations and trade names include: Abilifi Asimtufii (aripiprazole extended-release 2-monthly injection), Azstarys (serdexmethylphenidate/dexmethylphenidate capsules), CAMCEVI (leuprolide 6-month slow-release SC depot injection), Drizalma Sprinkle (duloxetine capsules), Eldepryl (selegiline tablets and capsules), Esprontia (topiramate oral solution), Exxua (gepirone extended-release tablets), Ketalar (ketamine hydrochloride injection), Lybalvi (olanzapine/samidorphan tablets), Onyda (clonidine extended-release suspension), Relexii (methylphenidate extended-release tablets), Secuado (asenapine transdermal patch), Zurzuvae (zuranolone capsules)

Do you want print and online? Deal with adults and children? Then combine CHPD publications and save. Click here for more information.